|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 483.60 CHF | -0.19% |
|
-4.07% | -10.06% |
| 03-09 | Lonza Extends Long-term Production Tie-up for Genetix's Gene Therapy | MT |
| 03-09 | Lonza Group and Genetix Biotherapeutics extend commercial manufacturing agreement for Zynteglo | RE |
| Capitalization | 34.03B 43.38B 37.63B 32.49B 59.09B 4,005B 61.16B 405B 161B 1,914B 163B 159B 6,907B | P/E ratio 2025 |
39.8x | P/E ratio 2026 * | 29.5x |
|---|---|---|---|---|---|
| Enterprise value | 37.49B 47.8B 41.46B 35.8B 65.11B 4,413B 67.39B 446B 177B 2,109B 179B 176B 7,610B | EV / Sales 2025 |
6.28x | EV / Sales 2026 * | 5.22x |
| Free-Float |
93.86% | Yield 2025 |
0.93% | Yield 2026 * | 1.12% |
Last Transcript: Lonza Group AG
| 1 day | -0.46% | ||
| 1 week | -4.46% | ||
| Current month | -10.16% | ||
| 1 month | -7.54% | ||
| 3 months | -7.93% | ||
| 6 months | -11.97% | ||
| Current year | -10.43% |
| 1 week | 478.7 | 509.6 | |
| 1 month | 478.7 | 542.4 | |
| Current year | 478.7 | 585.6 | |
| 1 year | 467.8 | 605.2 | |
| 3 years | 308.6 | 616 | |
| 5 years | 308.6 | 785.4 | |
| 10 years | 152.8 | 785.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wolfgang Wienand
CEO | Chief Executive Officer | 54 | 30/06/2024 |
Philippe Deecke
DFI | Director of Finance/CFO | 54 | 30/11/2021 |
Daniel Buchta
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Barbara Richmond
BRD | Director/Board Member | 65 | 15/04/2014 |
| Director/Board Member | 68 | 15/04/2014 | |
Christoph Mäder
BRD | Director/Board Member | 66 | 25/04/2016 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.46% | -4.46% | -10.90% | -8.42% | 43.38B | ||
| -4.55% | -2.61% | +14.19% | +31.94% | 31.64B | ||
| -1.44% | -2.60% | +14.63% | +45.41% | 30.26B | ||
| -5.04% | -8.72% | -12.13% | -17.40% | 27.35B | ||
| -4.54% | -4.59% | +142.53% | +357.95% | 18.84B | ||
| +0.66% | -3.51% | +52.36% | +115.62% | 14.06B | ||
| -7.09% | -5.44% | +36.61% | +153.01% | 12.6B | ||
| -0.32% | -4.80% | +21.98% | -2.54% | 12.52B | ||
| -3.28% | -3.75% | +116.52% | +113.02% | 11.95B | ||
| +1.44% | -0.87% | +21,619.46% | +3,341.35% | 11.87B | ||
| Average | -2.46% | -4.45% | +2,199.53% | +412.99% | 21.45B | |
| Weighted average by Cap. | -2.50% | -4.68% | +1,222.67% | +246.26% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 7.57B 9.65B 8.37B 7.22B 13.14B 891B 13.6B 90.05B 35.76B 426B 36.2B 35.43B 1,536B | 7.14B 9.1B 7.9B 6.82B 12.4B 840B 12.83B 84.96B 33.74B 402B 34.16B 33.43B 1,449B |
| Net income | 1.03B 1.31B 1.14B 980M 1.78B 121B 1.85B 12.22B 4.85B 57.73B 4.91B 4.81B 208B | 1.17B 1.49B 1.3B 1.12B 2.03B 138B 2.1B 13.94B 5.53B 65.86B 5.6B 5.48B 238B |
| Net Debt | 3.46B 4.42B 3.83B 3.31B 6.01B 408B 6.22B 41.22B 16.37B 195B 16.57B 16.22B 703B | 3.23B 4.12B 3.58B 3.09B 5.62B 381B 5.81B 38.49B 15.28B 182B 15.47B 15.14B 656B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/03/26 | 483.80 CHF | -0.14% | 50,393 |
| 12/03/26 | 484.50 CHF | -1.04% | 145,875 |
| 11/03/26 | 489.60 CHF | -1.39% | 201,508 |
| 10/03/26 | 496.50 CHF | -0.44% | 127,275 |
| 09/03/26 | 498.70 CHF | -1.09% | 193,292 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- LONN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition

















